Moderna creates new executive committee role for product launches
Juan Andres Appointed to President, Strategic Partnerships and Enterprise Expansion
Juan Andres Appointed to President, Strategic Partnerships and Enterprise Expansion
The proposed acquisition consideration represents an equity value for Myovant of $2.4 billion and an enterprise value of $2.5 billion.
There is also a growing interest in whole generation sequencing (WGS)
Dr. Bunker will focus on leading Research and Development (R&D) in San Diego, advancing the preclinical pipeline and optimizing the Company’s Integrated Discovery Engine.
Transformation to pure-play Innovative Medicines company nears completion
This newly launched institute will be the centre of excellence in the treatment of all cancers under a single roof.
Lenalidomide is used to treat various types of cancers.
NULIBRY is a first-in-class cPMP substrate replacement therapy to reduce the risk of mortality in patients with MoCD Type A.
Singapore presents great opportunities for the adoption of technology in healthcare and is open for investments
Subscribe To Our Newsletter & Stay Updated